Holly Rawizza
- Virology top 5%
- HIV Research and Treatment 10
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment 13
- HIV/AIDS Research and Interventions 12
- Tuberculosis Research and Epidemiology 2
-
- Pneumocystis jirovecii pneumonia detection and treatment 6
-
- HIV-related health complications and treatments 3
-
- Pharmacological Effects and Toxicity Studies 3
-
- LGBTQ Health, Identity, and Policy 1
- Co-authors
- Seema MeloniProsper OkonkwoPhyllis J. KankiCharlotte A. ChangBeth ChaplinGeoffrey EisenOche AgbajiBolanle Banigbe
- Partner nations
- United StatesNigeriaSouth Africa
In The Last Decade
Holly Rawizza
18 papers receiving 324 citations
Peers
Comparison fields: 5 of 44
- Virology 174
- Infectious Diseases 313
- Epidemiology 112
- Emergency Medicine 21
- General Health Professions 45
Countries citing papers authored by Holly Rawizza
This map shows the geographic impact of Holly Rawizza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Holly Rawizza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Holly Rawizza more than expected).
Fields of papers citing papers by Holly Rawizza
This network shows the impact of papers produced by Holly Rawizza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Holly Rawizza. The network helps show where Holly Rawizza may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Holly Rawizza, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2022 | 5 | |
| 5 | 2020 | 13 | |
| 6 | 2020 | 2 | |
| 7 | 2019 | 4 | |
| 8 | INCIDENCE OF ANAEMIA AMONG HIV-INFECTED PATIENTS TREATED WITH ZIDOVUDINE-CONTAINING ANTIRETROVIRAL THERAPY IN NORTHEASTERN NIGERIA. | 2018 | 6 |
| 9 | 2017 | 4 | |
| 10 | 2016 | 3 | |
| 11 | 2015 | 8 | |
| 12 | 2015 | 40 | |
| 13 | 2015 | 11 | |
| 14 | 2015 | 22 | |
| 15 | 2014 | 48 | |
| 16 | 2013 | 6 | |
| 17 | 2013 | 34 | |
| 18 | 2011 | 1 | |
| 19 | 2011 | 117 | |
| 20 | Pharmacokinetic interactions between ritonavir-boosted darunavir and NNRTIs: a report of 3 cases. | 2008 | 4 |
About Holly Rawizza
Holly Rawizza is a scholar working on Virology, Infectious Diseases and Emergency Medicine, having authored 22 papers that have together received 332 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (13 papers), HIV/AIDS Research and Interventions (12 papers), HIV Research and Treatment (10 papers), Pneumocystis jirovecii pneumonia detection and treatment (6 papers), Pharmacological Effects and Toxicity Studies (3 papers), HIV-related health complications and treatments (3 papers), Tuberculosis Research and Epidemiology (2 papers) and LGBTQ Health, Identity, and Policy (1 paper). The work is most often cited by research in Virology (174 citations), Infectious Diseases (313 citations) and Epidemiology (112 citations). Holly Rawizza has collaborated with scholars based in United States, Nigeria and South Africa. Frequent co-authors include Seema Meloni, Prosper Okonkwo, Phyllis J. Kanki, Charlotte A. Chang, Beth Chaplin, Beth Chaplin, Geoffrey Eisen, Oche Agbaji, Bolanle Banigbe and Obinna Onwujekwe.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.